PharmaBio Serv (PBSV)
(Delayed Data from OTC)
$0.85 USD
0.00 (0.00%)
Updated Mar 27, 2024 01:08 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for PharmaBio Serv Inc falls in the month of October.
All items in Millions except Per Share data.
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 15 | 14 | 17 | 17 | 15 |
Receivables | 4 | 5 | 5 | 10 | 9 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 0 | 1 | 1 | 2 | 2 |
Total Current Assets | 19 | 20 | 23 | 29 | 26 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 20 | 21 | 24 | 30 | 27 |
Liabilities & Shareholders Equity | 10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 2 | 2 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 1 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 1 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 2 |
Total Current Liabilities | 2 | 2 | 3 | 4 | 4 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 1 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 2 | 2 | 2 | 2 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4 | 4 | 5 | 7 | 6 |
Shareholders Equity | 10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2 | 2 | 1 | 1 | 1 |
Retained Earnings | 15 | 15 | 18 | 22 | 19 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 1 | 1 | 0 | 0 | 0 |
Total Shareholder's Equity | 16 | 17 | 19 | 23 | 21 |
Total Liabilities & Shareholder's Equity | 20 | 21 | 24 | 30 | 27 |
Total Common Equity | 16 | 17 | 19 | 23 | 21 |
Shares Outstanding | 22.90 | 23.40 | 23.40 | 23.40 | 23.40 |
Book Value Per Share | 0.70 | 0.71 | 0.81 | 0.97 | 0.88 |
Fiscal Year End for PharmaBio Serv Inc falls in the month of October.
All items in Millions except Per Share data.
1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 16 | 15 | 15 | 14 | 15 |
Receivables | 2 | 4 | 5 | 5 | 4 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 0 | 0 | 1 | 0 | 0 |
Total Current Assets | 19 | 19 | 20 | 19 | 20 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 19 | 20 | 20 | 20 | 21 |
Liabilities & Shareholders Equity | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 2 | 2 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 1 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 1 | 1 | 1 | 0 |
Other Current Liabilities | 2 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 4 | 2 | 2 | 2 | 2 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 1 | 1 | 2 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 5 | 4 | 4 | 4 | 4 |
Shareholders Equity | 1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | 1/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2 | 2 | 2 | 2 | 2 |
Retained Earnings | 13 | 15 | 15 | 14 | 16 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 1 | 1 | 1 | 1 | 1 |
Total Shareholder's Equity | 14 | 16 | 16 | 16 | 17 |
Total Liabilities & Shareholder's Equity | 19 | 20 | 20 | 20 | 21 |
Total Common Equity | 14 | 16 | 16 | 16 | 17 |
Shares Outstanding | 22.90 | 22.90 | 22.90 | 22.90 | 23.40 |
Book Value Per Share | 0.62 | 0.70 | 0.71 | 0.68 | 0.73 |